There is no way Allogene Therapeutics Inc (ALLO) can keep these numbers up
With 2.12 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.23 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.36 whereas the lowest price it dropped to was $1.2646. The 52-week range on ALLO shows […]
There is no doubt that Allogene Therapeutics Inc (ALLO) ticks all the boxes.
With 1.67 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.26 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.39 whereas the lowest price it dropped to was $1.29. The 52-week range on ALLO shows […]
A better buy-in window may exist right now for Allogene Therapeutics Inc (ALLO)
With 3.47 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.35 million shares. The 52-week range on ALLO shows that it touched its highest point at $3.78 and its lowest point at $0.86 during that stretch. It currently has a 1-year price target of $8.15. Beta for […]
Perhaps timely catching Allogene Therapeutics Inc (ALLO) would be a good idea
With 3.0 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.38 million shares. The 52-week range on ALLO shows that it touched its highest point at $3.78 and its lowest point at $0.86 during that stretch. It currently has a 1-year price target of $8.20. Beta for […]
Healthy Upside Potential: Allogene Therapeutics Inc (ALLO)
With 3.13 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.65 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.17 whereas the lowest price it dropped to was $1.07. The 52-week range on ALLO shows […]
Take off with Allogene Therapeutics Inc (ALLO): Get ready for trading
With 5.77 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.4 million shares. The 52-week range on ALLO shows that it touched its highest point at $3.78 and its lowest point at $1.23 during that stretch. It currently has a 1-year price target of $9.18. Beta for […]
This trade activity should not be overlooked: Allogene Therapeutics Inc (ALLO)
With 2.28 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.36 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.64 whereas the lowest price it dropped to was $1.49. The 52-week range on ALLO shows […]
